Details of the Drug
General Information of Drug (ID: DMIRBYE)
Drug Name |
Fluoro-Phosphite Ion
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Fluorophosphate; FLUORO-PHOSPHITE ION; Phosphorofluoridate; UNII-4964UZ79MI; 15181-43-8; 4964UZ79MI; Monofluorophosphate(2-); Fluorotrioxophosphate(2-); Fluorophosphate (FPO32-); Monofluorophostae (PO3F2-); fluoridophosphate; Fluorophosphate ion (PFO32-); fluoro-dioxido-oxo-; AC1L22VV; fluoridotrioxidophosphate(2-); Phosphorofluoridate(8CI,9CI); CHEBI:42699; CTK0H6578; DTXSID90164882; 7789-74-4 (calcium salt); 15600-53-0 (barium salt); DB02348; [PFO3](2-); 10163-15-2 (di-hydrochloride salt); 7631-97-2 (unspecified hydrochloride sa
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 97.97 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -1.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||